Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (181-190 of 426) with videos related to

Pageof 43
Sort By:
The Journal of Clinical Investigation|June 1, 1974
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemiaJ A Charlesworth, D G Williams, E Sherington, et al.
The Journal of Clinical Investigation|March 1, 1975
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiencyJ B Ziegler, C A Alper, R S Rosen, et al.
Allergy|October 1, 1994
The profiles of interleukin (IL)-2, IL-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic diseaseS M McHugh, A B Wilson, J Deighton, et al.
Immunology|May 1, 1992
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59M G Wing, J Zajicek, D J Seilly, et al.
European Journal of Immunology|June 1, 1985
Human clones with natural killer function can activate B cells and secrete B cell differentiation factorsA Vyakarnam, M K Brenner, J E Reittie, et al.
Nature Clinical Practice. Cardiovascular Medicine|December 17, 2008
Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutationAshutosh D Wechalekar, Mark Offer, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 27, 2017
Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiologyThirusha Lane, Ashutosh D Wechalekar, Julian D Gillmore, et al.
Biological Trace Element Research|November 23, 2013
Tissue-and metal-specific effects of thiolacrylic acids in ratsE Giroux, P J Lachmann, H G Petering, et al.
Clinical and Experimental Immunology|June 1, 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitroN Amos, J G Sissons, J F Girard, et al.
Clinical and Experimental Immunology|March 1, 1975
Immunoconglutinins and C3 in human salivaB D Williams, S J Challacombe, J M Slaney, et al.
Pageof 43

Showing results (181-190 of 426) with videos related to

Sort By:
Pageof 43
The Journal of Clinical Investigation|June 1, 1974
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemiaJ A Charlesworth, D G Williams, E Sherington, et al.
The Journal of Clinical Investigation|March 1, 1975
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiencyJ B Ziegler, C A Alper, R S Rosen, et al.
Allergy|October 1, 1994
The profiles of interleukin (IL)-2, IL-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic diseaseS M McHugh, A B Wilson, J Deighton, et al.
Immunology|May 1, 1992
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59M G Wing, J Zajicek, D J Seilly, et al.
European Journal of Immunology|June 1, 1985
Human clones with natural killer function can activate B cells and secrete B cell differentiation factorsA Vyakarnam, M K Brenner, J E Reittie, et al.
Nature Clinical Practice. Cardiovascular Medicine|December 17, 2008
Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutationAshutosh D Wechalekar, Mark Offer, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 27, 2017
Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiologyThirusha Lane, Ashutosh D Wechalekar, Julian D Gillmore, et al.
Biological Trace Element Research|November 23, 2013
Tissue-and metal-specific effects of thiolacrylic acids in ratsE Giroux, P J Lachmann, H G Petering, et al.
Clinical and Experimental Immunology|June 1, 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitroN Amos, J G Sissons, J F Girard, et al.
Clinical and Experimental Immunology|March 1, 1975
Immunoconglutinins and C3 in human salivaB D Williams, S J Challacombe, J M Slaney, et al.
Pageof 43